Application 209600

Type: ANDA
Sponsor: ACCORD HLTHCARE INC

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	AMLODIPINE AND OLMESARTAN MEDOXOMIL	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	TABLET;ORAL	EQ 5MG BASE;20MG	No	No
002	AMLODIPINE AND OLMESARTAN MEDOXOMIL	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	TABLET;ORAL	EQ 10MG BASE;20MG	No	No
003	AMLODIPINE AND OLMESARTAN MEDOXOMIL	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	TABLET;ORAL	EQ 5MG BASE;40MG	No	No
004	AMLODIPINE AND OLMESARTAN MEDOXOMIL	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	TABLET;ORAL	EQ 10MG BASE;40MG	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	Approval date
A209600-001	AMLODIPINE AND OLMESARTAN MEDOXOMIL	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	EQ 5MG BASE;20MG	TABLET / ORAL	2018-08-30
A209600-002	AMLODIPINE AND OLMESARTAN MEDOXOMIL	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	EQ 10MG BASE;20MG	TABLET / ORAL	2018-08-30
A209600-003	AMLODIPINE AND OLMESARTAN MEDOXOMIL	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	EQ 5MG BASE;40MG	TABLET / ORAL	2018-08-30
A209600-004	AMLODIPINE AND OLMESARTAN MEDOXOMIL	AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL	EQ 10MG BASE;40MG	TABLET / ORAL	2018-08-30

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 2 of 5 · 176 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209600-001	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;20MG	TABLET / ORAL	2018-08-30	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209600-002	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;20MG	TABLET / ORAL	2018-08-30	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209600-003	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;40MG	TABLET / ORAL	2018-08-30	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209600-004	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;40MG	TABLET / ORAL	2018-08-30	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209600-001	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;20MG	TABLET / ORAL	2018-08-30	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209600-002	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;20MG	TABLET / ORAL	2018-08-30	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209600-003	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;40MG	TABLET / ORAL	2018-08-30	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209600-004	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;40MG	TABLET / ORAL	2018-08-30	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A209600-001	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;20MG	TABLET / ORAL	2018-08-30	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A209600-002	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;20MG	TABLET / ORAL	2018-08-30	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A209600-003	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;40MG	TABLET / ORAL	2018-08-30	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A209600-004	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;40MG	TABLET / ORAL	2018-08-30	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A209600-001	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;20MG	TABLET / ORAL	2018-08-30	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A209600-002	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;20MG	TABLET / ORAL	2018-08-30	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A209600-003	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;40MG	TABLET / ORAL	2018-08-30	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A209600-004	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;40MG	TABLET / ORAL	2018-08-30	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A209600-001	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;20MG	TABLET / ORAL	2018-08-30	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A209600-002	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;20MG	TABLET / ORAL	2018-08-30	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A209600-003	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;40MG	TABLET / ORAL	2018-08-30	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A209600-004	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;40MG	TABLET / ORAL	2018-08-30	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A209600-001	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;20MG	TABLET / ORAL	2018-08-30	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A209600-002	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;20MG	TABLET / ORAL	2018-08-30	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A209600-003	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;40MG	TABLET / ORAL	2018-08-30	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A209600-004	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;40MG	TABLET / ORAL	2018-08-30	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A209600-001	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;20MG	TABLET / ORAL	2018-08-30	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A209600-002	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;20MG	TABLET / ORAL	2018-08-30	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A209600-003	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;40MG	TABLET / ORAL	2018-08-30	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A209600-004	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;40MG	TABLET / ORAL	2018-08-30	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A209600-001	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;20MG	TABLET / ORAL	2018-08-30	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A209600-002	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;20MG	TABLET / ORAL	2018-08-30	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A209600-003	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;40MG	TABLET / ORAL	2018-08-30	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A209600-004	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;40MG	TABLET / ORAL	2018-08-30	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A209600-001	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;20MG	TABLET / ORAL	2018-08-30	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A209600-002	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;20MG	TABLET / ORAL	2018-08-30	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A209600-003	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;40MG	TABLET / ORAL	2018-08-30	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A209600-004	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;40MG	TABLET / ORAL	2018-08-30	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A209600-001	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;20MG	TABLET / ORAL	2018-08-30	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A209600-002	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;20MG	TABLET / ORAL	2018-08-30	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A209600-003	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 5MG BASE;40MG	TABLET / ORAL	2018-08-30	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A209600-004	AMLODIPINE AND OLMESARTAN MEDOXOMIL	EQ 10MG BASE;40MG	TABLET / ORAL	2018-08-30	`4b0b4de00fa7…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 10 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Amlodipine and Olmesartan Medoxomil	AMLODIPINE AND OLMESARTAN MEDOXOMIL	A-S Medication Solutions	350c7317-a92d-4bcb-973f-19d6de87ed83	2026-01-24	Boxed warning, Warnings, Adverse reactions	Name fallback brand name: Amlodipine and Olmesartan Medoxomil
Amlodipine and Olmesartan Medoxomil	AMLODIPINE AND OLMESARTAN MEDOXOMIL	AvKARE	1b30c3fe-5c84-0d42-e063-6394a90a81d8	2026-01-13	Boxed warning, Warnings, Adverse reactions	Name fallback brand name: Amlodipine and Olmesartan Medoxomil
AMLODIPINE and OLMESARTAN medoxomil	AMLODIPINE AND OLMESARTAN MEDOXOMIL	Macleods Pharmaceuticals Limited	c86a3c45-c906-46c9-9f7b-6c3d89bbe48f	2026-01-03	Boxed warning, Warnings, Adverse reactions	Name fallback brand name: AMLODIPINE and OLMESARTAN medoxomil
Amlodipine and olmesartan Medoxomil	AMLODIPINE AND OLMESARTAN MEDOXOMIL	Ascend Laboratories, LLC	c1204fbe-d086-43cf-bbaa-efec9cd0487c	2025-05-30	Boxed warning, Warnings, Adverse reactions	Name fallback brand name: Amlodipine and olmesartan Medoxomil
Amlodipine and Olmesartan Medoxomil	AMLODIPINE AND OLMESARTAN MEDOXOMIL	Camber Pharmaceuticals, Inc.	99865c67-5475-4e60-98d5-a8fa850fe9ba	2025-03-26	Boxed warning, Warnings, Adverse reactions	Name fallback brand name: Amlodipine and Olmesartan Medoxomil
AMLODIPINE AND OLMESARTAN MEDOXOMIL	AMLODIPINE AND OLMESARTAN MEDOXOMIL	Micro Labs Limited	7fcf6a87-7b3e-4cef-8c47-c8a008cfea82	2025-01-09	Boxed warning, Warnings, Adverse reactions	Name fallback brand name: AMLODIPINE AND OLMESARTAN MEDOXOMIL
AMLODIPINE AND OLMESARTAN MEDOXOMIL	AMLODIPINE AND OLMESARTAN MEDOXOMIL	Bryant Ranch Prepack	f16c4254-fb35-408e-9419-e17d684ea5ac	2024-08-15	Boxed warning, Warnings, Adverse reactions	Name fallback brand name: AMLODIPINE AND OLMESARTAN MEDOXOMIL
Amlodipine and Olmesartan Medoxomil	AMLODIPINE AND OLMESARTAN MEDOXOMIL	Aurobindo Pharma Limited	b13a8b46-104e-4b75-8f4a-928d2204eff5	2024-04-15	Boxed warning, Warnings, Adverse reactions	Name fallback brand name: Amlodipine and Olmesartan Medoxomil
Amlodipine and Olmesartan Medoxomil	AMLODIPINE AND OLMESARTAN MEDOXOMIL	Amneal Pharmaceuticals NY LLC	02f9b562-6f7f-4783-bb0d-67c318073e1c	2024-03-26	Boxed warning, Warnings, Adverse reactions	Name fallback brand name: Amlodipine and Olmesartan Medoxomil
Amlodipine and Olmesartan Medoxomil	AMLODIPINE AND OLMESARTAN MEDOXOMIL	Glenmark Pharmaceuticals Inc., USA	2edf43fb-0755-4ffb-bc38-75a4e2432588	2021-02-28	Boxed warning, Warnings, Adverse reactions	Name fallback brand name: Amlodipine and Olmesartan Medoxomil

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.